Skin Efficacy Testing of Astrion Products

Chia Nan University of Pharmacy ＆ Science

Status: Completed

Conditions: Skin Pigment; Skin Red

Treatments: Dietary Supplement: Oral Treatment + Topical Treatment Group; Dietary Supplement: ACS Topical Treatment Group; Dietary Supplement: Topical Placebo Group; Dietary Supplement: Oral Treatment + Topical Placebo Group; Dietary Supplement: Oral Placebo Group; Dietary Supplement: ACS Oral Treatment Group

Study type: Interventional

Funder types: Other

Identifiers

NCT06657352

TSMHIRB22-111-A

Details and patient eligibility

About

This project aims to conduct safety and efficacy tests on the skin for the ingestion of Astrion Vitality Capsules, containing A. membranaceus and C. Asiatica roots, and the topical application of Astrion Vitality Cream. The goal is to develop health and skincare products that regulate physiological functions, promote overall wellness, and enhance skin beauty.

Enrollment: 150 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Subjects aged ≥18 years.

Exclusion criteria

• Non-voluntary participants.
• Subjects diagnosed with skin diseases, cirrhosis, or chronic renal failure by a -physician.
• Individuals with known allergies to cosmetics, drugs, or food.
• Pregnant or breastfeeding women.
• Individuals taking medication for chronic diseases.
• Subjects who, within 12 weeks prior to the test, have undergone laser facial treatments, chemical peels, or experienced prolonged sun exposure (more than 3 hours of direct sunlight in a week).
• Students taught by the investigator.
• Individuals unwilling to allow the publication of photos of the experimental results.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

150 participants in 6 patient groups, including a placebo group

ACS Topical Treatment Group

Experimental group

Description:

25 participants, measured at Week 0, 2, 4.

Treatment:

Dietary Supplement: ACS Topical Treatment Group

Topical Placebo Group

Placebo Comparator group

Description:

25 participants, measured at Week 0, 2, 4.

Treatment:

Dietary Supplement: Topical Placebo Group

ACS Oral Treatment Group

Experimental group

Description:

25 participants, measured at Week 0, 2, 4, 8, 12.

Treatment:

Dietary Supplement: ACS Oral Treatment Group

Oral Placebo Group

Placebo Comparator group

Description:

25 participants, measured at Week 0, 2, 4, 8, 12.

Treatment:

Dietary Supplement: Oral Placebo Group

ACS Oral Treatment + ACS Topical Treatment Group

Experimental group

Description:

25 participants, measured at Week 0, 2, 4, 8, 12.

Treatment:

Dietary Supplement: Oral Treatment + Topical Treatment Group

ACS Oral Treatment + Topical Placebo Group

Placebo Comparator group

Description:

25 participants, measured at Week 0, 2, 4, 8, 12.

Treatment:

Dietary Supplement: Oral Treatment + Topical Placebo Group